Multiple alternate p21 transcripts are regulated by p53 in human cells

Oncogene

Volumn 25, Issue 12, 2006, Pages 1812-1815

  Radhakrishnan, S K ^a   Gierut, J ^a   Gartel, A L ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Alternate transcript; Basal transcription; p21; p53

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; ISOPROTEIN; PROTEIN P21; PROTEIN P21 ALT A; PROTEIN P21 ALT B; PROTEIN P21 ALT C; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA RESPONSIVE ELEMENT; GENE LOCUS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; KNOCKOUT GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN VARIANT; REGULATORY MECHANISM; TRANSCRIPTION INITIATION SITE; UPREGULATION;

ALTERNATIVE SPLICING; BASE SEQUENCE; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; HUMANS; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33644775019     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209195     Document Type: Article

References (23)

1. Bartel F, Taubert H, Harris LC. (2002). Cancer Cell 2: 9-15.
2. Chen B, He L, Savell VH, Jenkins JJ, Parham DM. (2000). Cancer Res 60: 3290-3298.
3. Chipuk JE, Maurer U, Green DR, Schuler M. (2003). Cancer Cell 4: 371-381.
4. Claus R, Lubbert M. (2003). Oncogene 22: 6489-6496.
5. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM et al. (1993). Cell 75: 817-825.
6. El-Deiry WS. (2003). Oncogene 22: 7486-7495.
7. Gartel AL, Radhakrishnan SK. (2005). Cancer Res 65: 3980-3985.
8. Gartel AL, Tyner AL. (1999). Exp Cell Res 246: 280-289.
9. Gartel AL, Radhakrishnan SK, Serfas MS, Kwon YH, Tyner AL. (2004). Oncogene 23: 8154-8157.
10. Gartel AL, Serfas MS, Tyner AL. (1996). Proc Soc Exp Biol Med 213: 138-149.
11. Giaccia AJ, Kastan MB. (1998). Genes Dev 12: 2973-2983.
12. Jeffers JR, Parganas E, Lee Y, Yang C, Wang J, Brennan J et al. (2003). Cancer Cell 4: 321-328.
13. Kaeser MD, Pebernard S, Iggo RD. (2004). J Biol Chem 279: 7598-7605.
14. Kubbutat MH, Jones SN, Vousden KH. (1997). Nature 387: 299-303.
15. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE et al. (1994). Science 266: 807-810.
16. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P et al. (2003). Mol Cell 11: 577-590.
17. Nakano K, Vousden KH. (2001). Mol Cell 7: 683-694.
18. Nozell S, Chen X. (2002). Oncogene 21: 1285-1294.
19. Phelps DE, Hsiao KM, Li Y, Hu N, Franklin DS, Westphal E et al. (1998). Mol Cell Biol 18: 2334-2343.
20. Slee EA, O'Connor DJ, Lu X. (2004). Oncogene 23: 2809-2818.
21. Tang HY, Zhao K, Pizzolato JF, Fonarev M, Langer JC, Manfredi JJ. (1998). J Biol Chem 273: 29156-29163.
22. Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B. (2001). Mol Cell 7: 673-682.
23. Zhu WG, Srinivasan K, Dai Z, Duan W, Druhan LJ, Ding H et al. (2003). Mol Cell Biol 23: 4056-4065.